Trademark: 79360498
Word
LIGEN
Status Date
Tuesday, May 14, 2024
Registration Number
7383355
Registration Date
Tuesday, May 14, 2024
Filing Date
Wednesday, November 23, 2022
Published for Opposition
Tuesday, February 27, 2024
9 Downloadable computer software for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; downloadable computer software for use by doctors and other medical professionals in capturing, tracking, reporting, analyzing health data in the field of medical decision support systems; downloadable virtual reality software for medical teaching, specifically, for granting user access to courses of instruction in the medical field; downloadable virtual screening software, specifically, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, and facilitates proof-of-concept testing in selected pre-clinical models; downloadable collaboration software platforms for use in database management in the field of medicine; downloadable computer software platforms for identifying new drugs in the nature of software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; downloadable artificial intelligence software for identifying new drugs in the nature of software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models in the field of healthcare
42 Software as a service (SAAS) services featuring software platforms using artificial intelligence for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; providing temporary use of online, non-downloadable artificial intelligence computer programs accessible via data networks for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; research in the field of artificial intelligence; design and development of computer software for operating medical technology in the nature of software for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; design and development of virtual screening software; design and development of virtual reality software for teaching medicine
The mark consists of the word "LIGEN" with a red dot between the L and I. The "LI" lettering appears in red, while "GEN" is in grey. To the left is a cube design in grey with a red sphere in the center, the left side of which creates a red "L" and "I," while the right side creates a grey "G". White indicates transparent matter and is not claimed as a feature of the mark.
LG LIGEN
The color(s) red and grey is/are claimed as a feature of the mark.
Sep 6, 2023
Assigned To Examiner
Jan 19, 2023
Sn Assigned For Sect 66a Appl From Ib
Jan 20, 2023
New Application Office Supplied Data Entered
Jan 24, 2023
Application Filing Receipt Mailed
Sep 6, 2023
Non-Final Action Written
Sep 7, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Sep 25, 2023
Refusal Processed By Mpu
Sep 25, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Oct 17, 2023
Refusal Processed By Ib
Jan 10, 2024
Teas Response To Office Action Received
Jan 10, 2024
Correspondence Received In Law Office
Jan 10, 2024
Teas/Email Correspondence Entered
Jan 11, 2024
Examiners Amendment -Written
Jan 11, 2024
Examiners Amendment E-Mailed
Jan 11, 2024
Notification Of Examiners Amendment E-Mailed
Jan 11, 2024
Examiner's Amendment Entered
Jan 11, 2024
Approved For Pub - Principal Register
Jan 23, 2024
Withdrawn From Pub - Og Review Query
Feb 7, 2024
Notification Of Possible Opposition Sent To Ib
Feb 7, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 26, 2024
Notification Processed By Ib
Feb 27, 2024
Published For Opposition
Mar 4, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 7, 2024
Notification Of Notice Of Publication E-Mailed
Feb 7, 2024
Official Gazette Publication Confirmation E-Mailed
May 14, 2024
Registered-Principal Register
May 14, 2024
Notice Of Registration Confirmation Emailed
Aug 14, 2024
Final Disposition Notice Created, To Be Sent To Ib
Trademark Alertz updated from USPTO on 2030-01-24
